Antipsychotics withdrawal in adults with intellectual disability and challenging behaviour: study protocol for a multicentre double-blind placebo-controlled randomised trial

BACKGROUND: In people with intellectual disability (ID) and challenging behaviour, antipsychotics (AP) are often used off-label and for a long period. Despite a lack of evidence for efficacy for challenging behaviour and concerns about common and clinically relevant side effects, complete withdrawal...

Descripción completa

Detalles Bibliográficos
Autores principales: Beumer, Sylvie, Hamers, Pauline, Oppewal, Alyt, Maes-Festen, Dederieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422779/
https://www.ncbi.nlm.nih.gov/pubmed/34488701
http://dx.doi.org/10.1186/s12888-021-03437-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422779/
https://www.ncbi.nlm.nih.gov/pubmed/34488701
http://dx.doi.org/10.1186/s12888-021-03437-2

Ejemplares similares